Clinical Trials Logo

Interstitial Lung Disease (ILD) clinical trials

View clinical trials related to Interstitial Lung Disease (ILD).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02758808 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis (IPF)

Pulmonary Fibrosis Foundation Patient Registry

PFFR
Start date: March 29, 2016
Phase:
Study type: Observational [Patient Registry]

The Pulmonary Fibrosis Foundation Patient Registry will collect data on at least 2,000 patients with interstitial lung disease (ILD) at approximately 40 clinical sites in the US. The Registry is targeting enrollment of approximately 60% of the 2,000 ILD participants to have idiopathic pulmonary fibrosis (IPF). The aim of the Registry is to create a cohort of well-characterized patients with interstitial lung disease (ILD) for participation in retrospective and prospective research

NCT ID: NCT02645968 Completed - Clinical trials for Interstitial Lung Disease (ILD)

Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING

EXCITING
Start date: May 2014
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to collect valid data from all forms of health care on the incidence, prevalence, the regional distribution, characteristics, management and outcomes of different ILDs under clinical practice conditions.